Evidence map›Paper›PMID 33476982›Full record

ArticleInternational immunopharmacology2021

Ozone therapy for the treatment of COVID-19 pneumonia: A scoping review.

Morteza Izadi, Luca Cegolon, Mohammad Javanbakht, Ali Sarafzadeh, Hassan Abolghasemi, Gholamhossein Alishiri, Shi Zhao, Behzad Einollahi, Mandana Kashaki, Nematollah Jonaidi-Jafari and 7 more

Open access · greenAbstract readScoping Review
In one paragraph

Article in International immunopharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 45 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Ozonated triglyceride protects against septic lethality via preventing the activation of NLRP3 inflammasome.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2023
    Article
  9. Article
  10. Article
  11. The Hidden Pandemic of COVID-19-Induced Organizing Pneumonia.Pharmaceuticals (Basel, Switzerland) · 2022
    Review
  12. Review
  13. Two Natural Flavonoid Substituted Polysaccharides fromMolecules (Basel, Switzerland) · 2022
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 3 countries.

Morteza IzadiHealth Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Luca CegolonLocal Health Unit N. 2 "Marca Trevigiana", Public Health Department, Treviso, Italy.
Mohammad JavanbakhtNephrology and Urology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran. Electronic address: mhmjvbt81@gmail.com.
Ali SarafzadehHealth Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran. Electronic address: Ali_sh_1993@yahoo.com.
Hassan AbolghasemiPediatric Congenital Hematologic Disorders Research Center, Research Institute for Children's Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Faculty of Medicine, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Gholamhossein AlishiriChemical Injuries Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Shi ZhaoJC School of Public Health and Primary Care, Chinese University of Hong Kong, Hong Kong, China.
Behzad EinollahiNephrology and Urology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Mandana KashakiShahid Akbarabadi Clinical Research Development, Unit (ShACRDU), Iran University of Medical Sciences (IUMS), Tehran, Iran.
Nematollah Jonaidi-JafariHealth Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Mosa AsadiNephrology and Urology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Ramezan JafariDepartment of Radiology, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Saeid FathiFellowship, Tehran University, Tehran, Iran.
Hassan NikoueinejadNephrology and Urology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Mehrdad EbrahimiNephrology and Urology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Sina ImanizadehStudent Research Committee (SRC), Baqiyatallah University of Medical Sciences, Tehran, Iran.
Amir Hosein GhazaleStudent Research Committee (SRC), Baqiyatallah University of Medical Sciences, Tehran, Iran.
Baqiyatallah University of Medical Sciences · IRAzienda ULSS 9 TREVISO · ITChinese University of Hong Kong · CNIran University of Medical Sciences · IRUniversity of Tehran · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe forms of COVID-19 can evolve into pneumonia, featured by acute respiratory failure due to acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). In viral diseases, the replication of viruses is seemingly stimulated by an imbalance between pro-oxidant and antioxidant activity as well as by the deprivation of antioxidant mechanisms. In COVID-19 pneumonia, oxidative stress also appears to be highly detrimental to lung tissues. Although inhaling ozone (O3) gas has been shown to be toxic to the lungs, recent evidence suggests that its administration via appropriate routes and at small doses can paradoxically induce an adaptive reaction capable of decreasing the endogenous oxidative stress. Ozone therapy is recommended to counter the disruptive effects of severe COVID-19 on lung tissues, especially if administered in early stages of the disease, thereby preventing the progression to ARDS.

Indexed as

SARS-CoV-2COVID-19HumansOxidants, PhotochemicalOzoneOxidants, PhotochemicalOzoneALIARDSCOVID-19Oxidative stressOzone (O3) thePneumonia

Identifiers

PMID33476982
PMCPMC7752030
OpenAlexW3115694488

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.